Logo-bi
Original Research
Mehdi Saberian, Hossein Hamzeiy, Ayuob Aghanejad, Davoud Asgari*
Bioimpacts. 2011;1(1): 31-36. doi: 10.5681/bi.2011.005
PMCID: PMC3648941     PMID: 23678405     Scopus ID: 84862153050    
PDF
XML
Cited By:
Review
Mehdi Saberian-Borujeni, Mohammad Johari-Ahar, Hossein Hamzeiy, Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2014;4(4): 205-215. doi: 10.15171/bi.2014.015
PMCID: PMC4298712     PMID: 25671177     Scopus ID: 84920996057    
PDF
XML
Cited By:
Original Research
Mohsen Ebrahimi, Mohammad Johari-Ahar, Hossein Hamzeiy*, Jaleh Barar ORCID, Omid Mashinchian, Yadollah Omidi* ORCID
Bioimpacts. 2012;2(2): 91-95. doi: 10.5681/bi.2012.013
PMCID: PMC3648926     PMID: 23678446     Scopus ID: 84865375417    
PDF
XML
Cited By:
Editorial
Ali Pourali, Yadollah Omidi* ORCID
Bioimpacts. 2023;13(2): 85-88. doi: 10.34172/bi.2023.22023
PMCID: PMC10182445     PMID: 37193078     Scopus ID: 85152106674    
Professor Yadollah Omidi has a Ph.D. degree in Pharmaceutical Sciences (2003, Cardiff University, UK) and completed a postdoctoral program (2004) at Cardiff University. He is currently working as a full professor at Nova Southeastern University College of Pharmacy, Florida. Prof. Omidi’s research in advanced targeted diagnosis and therapy of diseases have resulted in over 300 published papers in international journals, 27 book chapters, and a few patents.


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge